Literature DB >> 16647761

Acceptability of routine screening for perinatal depression.

Anne Buist1, John Condon, Janette Brooks, Craig Speelman, Jeannette Milgrom, Barbara Hayes, David Ellwood, Bryanne Barnett, Nick Kowalenko, Stephen Matthey, Marie-Paule Austin, Justin Bilszta.   

Abstract

BACKGROUND: To assess the acceptability of routine screening for perinatal depression.
METHOD: Postnatal women (n=860) and health professionals (n=916) were surveyed after 3 years of routine perinatal (antenatal and postnatal) use of the Edinburgh Postnatal Depression Scale (EPDS).
RESULTS: Over 90% of women had the screening explained to them and found the EPDS easy to complete; 85% had no difficulties completing it. Discomfort with screening was significantly related to having a higher EPDS score. A majority of health professionals using the EPDS was comfortable and found it useful. LIMITATIONS: The sample involved only maternity services supporting depression screening. In addition, the response rate from GPs was low.
CONCLUSIONS: Routine screening with the EPDS is acceptable to most women and health professionals. Sensitive explanation, along with staff training and support, is essential in implementing depression screening.

Entities:  

Mesh:

Year:  2006        PMID: 16647761     DOI: 10.1016/j.jad.2006.02.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  35 in total

Review 1.  Prenatal and postpartum maternal psychological distress and infant development: a systematic review.

Authors:  Dawn Kingston; Suzanne Tough; Heather Whitfield
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

2.  Nursing care for postpartum depression, part 1: do nurses think they should offer both screening and counseling?

Authors:  Lisa S Segre; Michael W O'Hara; Stephan Arndt; Cheryl Tatano Beck
Journal:  MCN Am J Matern Child Nurs       Date:  2010 Jul-Aug       Impact factor: 1.412

3.  Identification of postpartum depression.

Authors:  Dorothy K Y Sit; Katherine L Wisner
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

4.  Screening and counseling for postpartum depression by nurses: the women's views.

Authors:  Lisa S Segre; Michael W O'Hara; Stephan Arndt; Cheryl T Beck
Journal:  MCN Am J Matern Child Nurs       Date:  2010 Sep-Oct       Impact factor: 1.412

5.  The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial.

Authors:  Ellen L Mozurkewich; Chelsea M Clinton; Julie L Chilimigras; Susan E Hamilton; Lucy J Allbaugh; Deborah R Berman; Sheila M Marcus; Vivian C Romero; Marjorie C Treadwell; Kristie L Keeton; Anjel M Vahratian; Ronald M Schrader; Jianwei Ren; Zora Djuric
Journal:  Am J Obstet Gynecol       Date:  2013-04       Impact factor: 8.661

6.  Primary Care Physicians' Attitudes Toward Postpartum Depression: Is It Part of Their Job?

Authors:  Saralee Glasser; Daphna Levinson; Rena Bina; Hanan Munitz; Ze'ev Horev; Giora Kaplan
Journal:  J Prim Care Community Health       Date:  2015-11-16

7.  Screening for depression in the postpartum period: a comparison of three instruments.

Authors:  Barbara H Hanusa; Sarah Hudson Scholle; Roger F Haskett; Kathleen Spadaro; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

8.  Postpartum depression screening at well-child visits: validity of a 2-question screen and the PHQ-9.

Authors:  Dwenda Gjerdingen; Scott Crow; Patricia McGovern; Michael Miner; Bruce Center
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

Review 9.  Antenatal psychosocial assessment for reducing perinatal mental health morbidity.

Authors:  Marie-Paule Austin; Susan R Priest; Elizabeth A Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

10.  The utility of screening for perinatal depression in the second trimester among Chinese: a three-wave prospective longitudinal study.

Authors:  Ying Lau; Daniel Fu Keung Wong; Kin Sin Chan
Journal:  Arch Womens Ment Health       Date:  2010-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.